BOULDER, Colo. – July 1, 2020 – PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, announced today the appointment of Tom Feeley to the position of Chief Financial Officer (CFO). Mr. Feeley began his role with PanTheryx on June 22 and reports to President and Chief Executive Officer Wes Parris. Mr. Feeley will be responsible for the development and execution of PanTheryx’s financial strategy including all Finance, Accounting and Treasury functions.
“Tom brings an ideal blend of financial and leadership skills coupled with nutrition industry experience that will be important as PanTheryx continues to expand its global leadership in colostrum commercialization focused in the nutrition and biotechnology sectors,” said Parris.
Mr. Feeley joins PanTheryx from DSM, where he most recently served as Vice President, Nutritional Lipids Category leading a diverse team in delivering exceptional business growth for DSM’s global omega-3 business. During his nine year tenure at DSM, Mr. Feeley also led the acquisition and integration of the world’s largest marine oil business, drove new product and technology innovations to increase market share, and led numerous programs to streamline operations, improve margins and reduce waste.
Prior to DSM, Mr. Feeley held various financial and operational leadership roles over a span of 13 years at Martek Biosciences Corporation. He was instrumental in creating Martek’s strategic plans and driving the development of organizational improvements that helped Martek grow from a fledgling technology company to a leading player in the infant nutrition ingredient space. Mr. Feeley is a Certified Public Accountant (CPA) and holds a BBA in finance and accounting from Loyola University.
“PanTheryx is driving a unique and powerful colostrum-based platform with the potential for numerous health and wellness applications. I could not be more excited to join the PanTheryx leadership team and contribute to the future success as the company progresses to the next phase of its growth strategy,” stated Feeley.
The addition of Tom Feeley is the latest in a recent line of appointments to the PanTheryx Management team and Board of Directors which reaffirm the company’s commitment to delivering best-in-class proprietary colostrum ingredients, forging new customer relationships, and driving research and development efforts designed to bring transformative health and wellness solutions to consumers worldwide.
PanTheryx™ is a nutrition and biotechnology company committed to the broad commercialization of bovine colostrum based health and wellness solutions for the global human and animal health markets. As the world’s largest producer of bovine colostrum, PanTheryx utilizes the cellular and biomolecular processes of bovine colostrum to develop and produce a wide range of therapeutics, spanning the range of nutritional interventions to biologics. PanTheryx’s proprietary colostrum, ColostrumOne™ is nature’s superfood; designed to be comprehensive as nature intended with the important nutritional components for health and vitality throughout all stages of life. Founded in 2007, PanTheryx is headquartered in Boulder, Colorado and has production facilities in Phoenix, AZ and Ripon, CA.
For additional information and the latest updates from the company, please visit PanTheryx.com